SNU-368 Cells
759,00 CAD$*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
Renseignements généraux
| Description | The SNU-368 cell line is a human hepatocellular carcinoma (HCC) model derived from a primary tumor of a 54-year-old male patient. This cell line is part of a panel of eight HCC cell lines established from Korean patients, designed to reflect the diverse molecular and phenotypic characteristics of liver cancers. SNU-368 cells exhibit a polygonal adherent morphology and display many histological features of the original tumor, including trabecular and acinar arrangements, which are characteristic of Edmondson grade II to IV differentiation. Genetically, SNU-368 cells harbor integrated hepatitis B virus (HBV) DNA and express HBV transcripts, including HBx and preS/S. These features make it a valuable model for studying HBV-related hepatocarcinogenesis. SNU-368 also expresses transferrin and insulin-like growth factor II (IGF-II), but it does not produce alpha-fetoprotein (AFP), either at the RNA or protein level. Such molecular characteristics are important for exploring liver cancer pathways associated with viral infection, growth factor signaling, and metabolic alterations. SNU-368 has been employed in pharmacogenomic studies, particularly in the Liver Cancer Model Repository (LIMORE), to investigate drug responses and identify potential biomarkers for targeted therapies. The cell line’s inclusion in large-scale genomic and transcriptomic analyses underscores its relevance in modeling the heterogeneity of primary HCCs, making it a robust tool for studying the molecular underpinnings of liver cancer and evaluating novel therapeutic agents. |
|---|---|
| Organisme | Human |
| Tissu | Liver |
| Maladie | hepatocellular carcinoma |
| Synonymes | SNU368 |
Caractéristiques
| Âge | 54 years |
|---|---|
| Genre | Male |
| Origine ethnique | Korean |
| Morphologie | Polygonal |
| Type de cellule | Endothelial |
| Propriétés de croissance | Adherent |
Données réglementaires
| Référence | SNU-368 (Cytion catalog number 305631) |
|---|---|
| Niveau de biosécurité | 2 |
| NCBI_Numéro d'identification fiscale | 9606 |
| Cellosaurus - Numéro d'enregistrement | CVCL_3948 |
Données biomoléculaires
| Virus | HBV |
|---|---|
| Profil mutationnel | Mutation: ARID1A, Simple, p.Leu1607Profs*41 (c.4817dupT), Unspecified; Mutation: AXIN1, Simple, p.Gln184Ter (c.550C>T), Unspecified; Mutation: TERT, Simple, c.1-124C>T (c.228C>T) (C228T), Unspecifie; Mutation: TP53, Simple, p.Ser106Arg (c.318C>G), Unspecified |
| Caryotype | Has lost chromosome Y. |
Manipulation
| Milieu de culture | RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
|---|---|
| Suppléments | Supplement the medium with 10% heat inactivated FBS |
| Réactif de dissociation | Accutase |
| Temps de doublement | 41 hours |
| Repiquage | Remove medium, add fresh 0.25 % trypsin 0.02 % EDTA solution, stand culture flask at 37''''C for 3 to 5 minutes, add culture medium and collect the cells, transfer the medium into 15ml tube, centrifuge, aspirate the medium, resuspend the pellets with culture medium and dispense into the culture flask |
| Renouvellement des fluides | 2 to 3 times per week |
| Milieu de congélation | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Décongélation et culture des cellules |
|
| Atmosphère d'incubation | 37°C, 5% CO2, humidified atmosphere. |
| Conditions d'expédition | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Conditions d'entreposage | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Contrôle de la qualité et analyse moléculaire
| Stérilité | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificat d'analyse (CoA)
| Numéro de lot | Type de certificat | Date | Numéro de catalogue |
|---|---|---|---|
| 305631-201125 | Certificat d'analyse | 15. Jan. 2026 | 305631 |